These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8148421)

  • 1. Acute parotitis during induction therapy including L-asparaginase in acute lymphoblastic leukemia.
    Sica S; Pagano L; Salutari P; Di Mario A; Rutella S; Leone G
    Ann Hematol; 1994 Feb; 68(2):91-2. PubMed ID: 8148421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia.
    Saburi M; Ogata M; Soga Y; Itani K; Kohno K; Nakayama T
    Intern Med; 2020 Jul; 59(14):1745-1748. PubMed ID: 32296003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
    Kathwate J; Mundada S; Patil P
    Indian J Cancer; 2014; 51(4):537. PubMed ID: 26842187
    [No Abstract]   [Full Text] [Related]  

  • 4. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
    Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
    Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperglycemia and acute parotitis related to L-asparaginase therapy.
    Uysal K; Uguz A; Olgun N; Sarialioglu F; Büyükgebiz A
    J Pediatr Endocrinol Metab; 1996; 9(6):627-9. PubMed ID: 9004180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
    Billett AL; Carls A; Gelber RD; Sallan SE
    Cancer; 1992 Jul; 70(1):201-6. PubMed ID: 1606543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
    Charan VD; Desai N; Singh AP; Choudhry VP
    Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
    [No Abstract]   [Full Text] [Related]  

  • 8. Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data.
    Nocentini F; Gugliotta L; Catani L; Vianelli N; Baravelli S; Martelli V; Tura S
    Haematologica; 1994; 79(6):546-9. PubMed ID: 7896215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
    Figueiredo L; Cole PD; Drachtman RA
    Expert Rev Hematol; 2016 Mar; 9(3):227-34. PubMed ID: 26765930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora.
    Belén LH; Lissabet JB; de Oliveira Rangel-Yagui C; Effer B; Monteiro G; Pessoa A; Farías Avendaño JG
    Biologicals; 2019 May; 59():47-55. PubMed ID: 30871932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
    Sahu S; Saika S; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia.
    Burke MJ
    Future Oncol; 2014 Dec; 10(16):2615-27. PubMed ID: 24983955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
    Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?
    Lashkari HP; Lancaster D; Atra A; Champion MP; Taj MM
    Int J Hematol; 2011 Dec; 94(6):571-5. PubMed ID: 22057510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
    Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
    Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study.
    Bigliardi S; Morselli M; Potenza L; Coluccio V; Maccaferri M; Paolini A; Colaci E; Fantuzzi V; Faglioni L; Soci F; Nasillo V; Messerotti A; Pedrazzi P; Marietta M; Luppi M; Forghieri F
    Leuk Lymphoma; 2015 Mar; 56(3):770-3. PubMed ID: 24991716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.